Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
- Status
- COMPLETED
- Phase
- N/A
Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
BG & TMZ Therapy of Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
- Status
- WITHDRAWN
- Phase
- PHASE3
Temozolomide in Elderly Patients With KPS < 70
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
- Status
- UNKNOWN
- Phase
- PHASE2
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
ABT-888 and Temozolomide for Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2